BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32431268)

  • 1. Noninvasive Models for Predicting Liver Fibrosis in Individuals with Hepatitis D Virus/Hepatitis B Virus Coinfection in the Brazilian Amazon Region.
    Alves Vasconcelos MP; DallÁcqua DV; Wedemeyer H; Witkin SS; Mendes-Corrêa MC; Villalobos-Salcedo JM
    Am J Trop Med Hyg; 2020 Jul; 103(1):169-174. PubMed ID: 32431268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive markers for staging fibrosis in chronic delta hepatitis.
    Takyar V; Surana P; Kleiner DE; Wilkins K; Hoofnagle JH; Liang TJ; Heller T; Koh C
    Aliment Pharmacol Ther; 2017 Jan; 45(1):127-138. PubMed ID: 27813124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection.
    Derbala M; Elbadri ME; Amer AM; AlKaabi S; Sultan KH; Kamel YM; Elsayed EH; Avades TY; Chandra P; Shebl FM
    World J Gastroenterol; 2015 Dec; 21(46):13132-9. PubMed ID: 26674154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
    Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
    Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of noninvasive tools for identification of minimal liver fibrosis in patients with hepatitis B virus infection.
    Zhang H; Shi X; Wang L; Zeng Y; Kang X; Huang L
    J Clin Lab Anal; 2021 Sep; 35(9):e23960. PubMed ID: 34403524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
    Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
    Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of FIB-6 score in assessment of liver fibrosis in chronic hepatitis B.
    Alswat K; Soliman R; Mikhail NNH; Örmeci N; Dalekos GN; Derbala MFM; Al-Busafi SA; Hamoudi W; Shiha G
    Saudi J Gastroenterol; 2024 May; 30(3):138-144. PubMed ID: 38482630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
    Shaikh S; Memon MS; Ghani H; Baloch GH; Jaffery M; Shaikh K
    J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection.
    Lee J; Kim MY; Kang SH; Kim J; Uh Y; Yoon KJ; Kim HS
    Br J Biomed Sci; 2018 Jul; 75(3):128-132. PubMed ID: 29893189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.
    Wang RQ; Zhang QS; Zhao SX; Niu XM; Du JH; Du HJ; Nan YM
    J Int Med Res; 2016 Dec; 44(6):1302-1313. PubMed ID: 28322102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.
    Amorim TG; Staub GJ; Lazzarotto C; Silva AP; Manes J; Ferronato Mda G; Shiozawa MB; Narciso-Schiavon JL; Dantas-Correa EB; Schiavon Lde L
    Ann Hepatol; 2012; 11(6):855-61. PubMed ID: 23109448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection.
    Zhu X; Wang LC; Chen EQ; Chen XB; Chen LY; Liu L; Lei XZ; Liu C; Tang H
    Dig Dis Sci; 2011 Sep; 56(9):2742-9. PubMed ID: 21399926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
    Cao X; Shang QH; Chi XL; Zhang W; Xiao HM; Sun MM; Chen G; An Y; Lv CL; Wang L; Nan YM; Chen CY; Tan ZN; Liu XE; Zhuang H
    World J Gastroenterol; 2020 Mar; 26(10):1067-1079. PubMed ID: 32205997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran.
    Moosavy SH; Eftekhar E; Davoodian P; Nejatizadeh A; Shadman M; Zare S; Nazarnezhad MA
    BMC Gastroenterol; 2023 May; 23(1):145. PubMed ID: 37170243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.